Form 8-K - Current report:
SEC Accession No. 0000950170-25-077233
Filing Date
2025-05-27
Accepted
2025-05-23 18:55:28
Documents
10
Period of Report
2025-05-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K amgn-20250523.htm   iXBRL 8-K 88549
  Complete submission text file 0000950170-25-077233.txt   223351

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amgn-20250523.xsd EX-101.SCH 43685
12 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20250523_htm.xml XML 6159
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 25983814
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)